Trademark: 97271830
Status Date
Monday, January 22, 2024
Filing Date
Thursday, February 17, 2022
Published for Opposition
Tuesday, January 10, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Jan 24, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 22, 2024
Sou Extension 1 Granted
Jan 22, 2024
Sou Extension 1 Filed
Jan 22, 2024
Sou Teas Extension Received
Aug 1, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 22, 2023
Ttab Release Case To Trademarks
Mar 20, 2023
Extension Of Time To Oppose Process - Terminated
Feb 8, 2023
Extension Of Time To Oppose Received
Jan 10, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 10, 2023
Published For Opposition
Dec 21, 2022
Notification Of Notice Of Publication E-Mailed
Dec 1, 2022
Approved For Pub - Principal Register
Dec 1, 2022
Assigned To Examiner
Oct 28, 2022
Teas Change Of Correspondence Received
Oct 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 23, 2022
New Application Office Supplied Data Entered
Feb 21, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24